I-Min Lee

Related Links

Biography

I-Min Lee, MBBS, MPH, ScD, FACSM is Professor of Medicine at Harvard Medical School and Professor of Epidemiology at the Harvard T.H. Chan School of Public Health. She was born and educated in Malaysia prior to receiving her medical degree from the National University of Singapore. She then completed her MPH and ScD degrees at the Harvard School of Public Health. Her primary research interest is in the role of physical activity for promoting health and well-being, and she has published more than 550 scientific articles. One of these, published by the Lancet in 2012 (http://www.bbc.co.uk/news/uk-wales-politics-18876880), that estimated the impact of physical inactivity on major non-communicable diseases has been highly influential in the field being cited more than 9,700 times to date.

She is editor or co-editor of physical activity epidemiology textbooks that have been translated into the Korean and Chinese languages. She has served on national and international expert panels developing physical activity guidelines including the inaugural 2008 US Physical Activity Guidelines, the 2010 WHO Global Recommendations on Physical Activity for Health, and the 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk, and sits on the Steering Committee of international Lancet Physical Activity Series. She is Principal Investigator of one of the first large-scale epidemiologic studies using accelerometers to measure physical activity and sedentary behavior among 18,000 participants in the Women’s Health Study from 2011 to 2015, who are currently being followed for health outcomes. Using these data, she was one of the first investigators to question whether the conventionally accepted 10,000 steps/day is necessary for health (https://www.nytimes.com/2021/07/06/well/move/10000-steps-health.html).

Publications

• Device-Measured 24-Hour Movement Behaviors and Blood Pressure: A 6-Part Compositional Individual Participant Data Analysis in the ProPASS Consortium.

  Blodgett JM, Ahmadi MN, Atkin AJ, Pulsford RM, Rangul V, Chastin S, Chan HW, Suorsa K, Bakker EA, Gupta N, Hettiarachchi P, Johansson PJ, Sherar LB, Del Pozo Cruz B, Koemel N, Mishra GD, Eijsvogels TMH, Stenholm S, Hughes AD, Teixeira-Pinto A, Ekelund U, Lee IM, Holtermann A, Koster A, Stamatakis E, Hamer M. Circulation 2024 Nov 06

• Biomarkers of glucose-insulin homeostasis and incident type 2 diabetes and cardiovascular disease: results from the Vitamin D and Omega-3 trial.

  Qian F, Guo Y, Li C, Liu Y, Luttmann-Gibson H, Gomelskaya N, Demler OV, Cook NR, Lee IM, Buring JE, Larsen J, Boring J, McPhaul MJ, Manson JE, Pradhan AD, Mora S. Cardiovasc Diabetol 2024 Nov 02

• Physical activity before and after cancer diagnosis and mortality risk in three large prospective cohorts.

  Christopher CN, Chandler PD, Zhang X, Tobias DK, Hazra A, Gaziano JM, Buring JE, Lee IM, Sesso HD. Cancer Causes Control 2024 Oct 08

• Potato Consumption and Risk of Type 2 Diabetes Mellitus: A Harmonized Analysis of 7 Prospective Cohorts.

  Djousse L, Zhou X, Lim J, Kim E, Sesso HD, Lee IM, Buring JE, McClelland RL, Gaziano JM, Steffen LM, Manson JE. J Nutr 2024

• Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women.

  Ridker PM, Moorthy MV, Cook NR, Rifai N, Lee IM, Buring JE. N Engl J Med 2024 Aug 31